IZOTROPIC CORP. Cash Flow Conversion Efficiency
IZOTROPIC CORP. cash flow conversion efficiency. Based on the latest financial reports, IZOTROPIC CORP. (1R3) has a cash flow conversion efficiency ratio of 0.023x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-130.84K ≈ $-152.96K USD) by net assets (€-5.63 Million ≈ $-6.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of IZOTROPIC CORP. (2022–2026)
Cash flow conversion efficiency of IZOTROPIC CORP. from 2022 to 2026. This chart illustrates how IZOTROPIC CORP.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View IZOTROPIC CORP. stock quote for real-time trading data and today's change.
IZOTROPIC CORP. Cash Flow Conversion Ratio Explained
IZOTROPIC CORP. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
IZOTROPIC CORP. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IZOTROPIC CORP. ranked by their cash flow conversion efficiency. Also see 1R3 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bulletin Resources Ltd
AU:BNR
|
-0.046x |
|
Masonglory Limited Ordinary Shares
NASDAQ:MSGY
|
-0.239x |
|
Sewon E&C
KO:091090
|
-0.052x |
|
Immuron Ltd ADR
NASDAQ:IMRN
|
-0.186x |
|
Activeport Group Ltd
AU:ATV
|
-0.155x |
|
Natural Health Trend
NASDAQ:NHTC
|
-0.090x |
|
Postmedia Network Canada Corp
TO:PNC-B
|
-0.023x |
|
Max Resource Corp
V:MAX
|
-0.058x |
Annual Cash Flow Conversion Efficiency for IZOTROPIC CORP. (2022–2026)
The table below shows the annual cash flow conversion efficiency of IZOTROPIC CORP. from 2022 to 2026. Review IZOTROPIC CORP. (1R3) financial flexibility to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-04-30 | €-5.63 Million ≈ $-6.58 Million |
€-851.25K ≈ $-995.20K |
0.151x | +15.58% |
| 2025-04-30 | €-4.86 Million ≈ $-5.68 Million |
€-636.23K ≈ $-743.82K |
0.131x | -15.15% |
| 2024-04-30 | €-3.85 Million ≈ $-4.50 Million |
€-593.57K ≈ $-693.95K |
0.154x | -85.48% |
| 2023-04-30 | €-3.07 Million ≈ $-3.59 Million |
€-3.27 Million ≈ $-3.82 Million |
1.063x | -91.64% |
| 2022-04-30 | €-374.59K ≈ $-437.93K |
€-4.76 Million ≈ $-5.57 Million |
12.718x | -- |
About IZOTROPIC CORP.
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.